NCT00770263View on ClinicalTrials.gov

Erlotinib and Temsirolimus for Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

46

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Solid Tumors

Interventions

DRUG

Erlotinib

DRUG

Temsirolimus

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Pfizer

INDUSTRY

lead

Washington University School of Medicine

OTHER

NCT00770263 - Erlotinib and Temsirolimus for Solid Tumors | Biotech Hunter | Biotech Hunter